Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Operating Expenses
Avid Bioservices Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Operating Expenses
-$33.8m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
5%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Operating Expenses
-$22.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Operating Expenses
-$11.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Operating Expenses
-$13.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Operating Expenses
-$5.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-16%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Operating Expenses
-$8.1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-16%
|
|
Avid Bioservices Inc
Glance View
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
See Also
What is Avid Bioservices Inc's Operating Expenses?
Operating Expenses
-33.8m
USD
Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Operating Expenses amounts to -33.8m USD.
What is Avid Bioservices Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
5%
Over the last year, the Operating Expenses growth was 0%. The average annual Operating Expenses growth rates for Avid Bioservices Inc have been -22% over the past three years , -18% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet